It mightn’t be too surprising Opthea (ASX:OPT) applied for a voluntary suspension last week ahead of Monday’s Phase 3 trial ...
Two of the first patients of adaptive Deep Brain Sitimulation (aDBS) Parkinson’s therapy and the neurologist who developed the care system share how life changes and how it doesn’t ...
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...
1h
Stockhead on MSNHealth Check: Opthea’s solvency in question after monumental phase III eye disease trial failureOne of two of Opthea's phase III trials for a common eye disease has failed to meet its primary endpoints, ... Read More The ...
FDA general secretary Dave Penman said a 10% cut in the entire salary bill of the Civil Service could mean up to 50,000 jobs ...
The Food and Drug Administration (FDA) issued the Class II recall of pouches of shredded cheese sold at ALDI's in four states ...
A new wave of menopause advocates, from journalists to founders, is pushing for change—challenging stigma and reshaping the ...
Soon after Borzelleca's paper was published in a scientific journal, Food and Chemical Toxicology, the FDA examined the data his team had collected and reached its own conclusion: that the dye caused ...
The FDA issued a warning to the barred seafood companies. Any attempt to enter the U.S. will lead to automatic detention at the border, without any physical inspection. This helps ensure that the ...
We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are ...
Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial resistance, which the ...
Across the U.S., a longtime push to ban synthetic dyes in food is gaining renewed momentum, with critics of the dyes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results